期刊文献+

药物性肝损伤临床调查及影响因素分析 被引量:37

Clinical investigation of drug induced liver injury and its influencing factors analysis
原文传递
导出
摘要 目的对药物性肝损伤(DILI)的临床特点进行总结归纳并分析其影响因素。方法对近2年DILI患者的临床资料进行回顾性分析。结果 DILI患者以男性较多(54%),用药以中药、抗结核药及联合用药居多。急性DILI中位发病时间为13 d,因药物种类而异,常见的临床症状有黄疸、乏力、纳差等。年龄、性别对其分型及预后无影响(P>0.05),分型以及起病时肝功能指标对DILI预后有明显影响(P<0.05)。结论 DILI目前尚无特异性临床症状,其预后与分型及起病时肝功能指标呈显著相关性。 Objective To summarize the clinical characteristics of drug-induced liver injury(DILI) and to analyze its influencing factors. Methods Common DILI diagnosis standard of our country was used to analyze the clinical data of hospitalized DILI patients in recent two years. Results One hundred and fifty patients with DILI were enrolled: male 83(53.55%), and traditional Chinese medicines and anti-tuberculosis drugs and drugs combination account for the major part of medication.The median onset time of DILI was the 13 d, which varied with drug species. Jaundice (60.65%) was the most common presenting symptom, and followed by anorexia(53.20%) ,weak(46.79%), nausea(20.51%), fever(20.51%).Age, and gender had no effects on DILI classification and prognosis(P>0.05). While there were significant differences in the relation between indexes of liver function and DILI classification with prognosis(P<0.05).Conclusion DILI has no specific clinical symptom, and its classification and indexes of liver function have effects on the prognosis of DILI.
机构地区 中南大学 中南大学
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2014年第3期216-218,共3页 The Chinese Journal of Clinical Pharmacology
关键词 药物性肝损伤 临床特点 影响因素 回顾性分析 drug-induced liver injury clinical characteristics influencing factors Retrospective analysis
  • 相关文献

参考文献14

  • 1Reuben A, Koch DG, Lee WM. Drug - induced acute liver failure : results of a U. S. multicenter, prospective study [ J]. Hepatology, 2010,52:2065 - 2076.
  • 2Devarbhavi H, Dierkhising R, Kremers WK, et al. Single - center experience with drug - induced liver injury from India: causes, out- come, prognosis, and predictors of mortality [ J ]. Am J Gastroener- ol,2010 ,105 :2396 - 2404.
  • 3Idilman R, Bcktas M, Cinar K, et al. The characteristics and clini- cal outcome of drug - induced liver injury: a single - center experi- ence [ J]. J Clin C, astroenterol, 2010, 44:128-132.
  • 4Chen M, Vijay V, Shi Q, et al. FDA - approved drug labeling for the study of drug - induced liver injury [ J ]. Drug Discov Today, 2011,16:697 - 703.
  • 5陈成伟.药物性肝损害诊断标准的评价[J].诊断学理论与实践,2009,8(2):121-124. 被引量:29
  • 6Aithal GP, Watkins PB, Andrade RJ, et al. Case definition and phenotype standardization in drug - induced liver injury [ J ]. Clin Pharmacol Ther ,2011,89 :806 - 815.
  • 7Russmann S, Kullak - Ublick GA, Grattagliano I. Current concepts of mechanisms in drug - induced hepatotoxicity [ J ]. Curr Med Chem, 2009,16:3041 - 3053.
  • 8Suk KT, Kim DJ. Drug - induced liver injury: present and future [J]. Clin Mol Hepatol ,2012 ,18 : 249 -257.
  • 9周光德,赵景民,张玲霞,孙艳玲,潘登,杨建法,赵雨来.药物性肝损伤100例临床病理分析[J].中华肝脏病杂志,2007,15(3):212-215. 被引量:29
  • 10Bunchomtavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity [ J]. Aliment Pharmacol Ther, 2013, 37:3 - 17.

二级参考文献20

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 2Bénichou C.Criteria of drug-induced liver disorders.Report of an international consensus meeting[J].J Hepatol,1990,11 (2):272-276.
  • 3Navarro V.Hepatic adverse event nomenclature document[EB/OL].(2006-11-17) http://www.fda.gov/cder/livertox/presentaions 2005/vic_Navarro.ppt.
  • 4舛本後 恩地森一.藁物性肝障害の诊断.肝胆胰,2000,40:887-897.
  • 5Danan G.Causality assessment of drug-induced liver injury[J].J Hepatol,1988,7(1):132-136.
  • 6Danan G,Benichou C.Causality assessment of adverse reactions to drugs-I.A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries[J].J Clin Epidemiol,1993,46(11):1323-1330.
  • 7Maria VA,Victorino RM.Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis[J].Hepatoiogy,1997,26(3):664-669.
  • 8Lucena MI,Camargo R,Andrade RJ,et al.Comparison of two clinical scales for causality assessment in hepatotoxicity[J].Hepatology,2001,33(1):123-130.
  • 9滝川一,恩地森一,高森赖雪,他.DDW-J2004 ヮ-クショップ药物性肝障害诊断基准の提案[J].肝臓,2005,46(2):85-90.
  • 10García-Cortés M,Lucena MI,Pachkoria K,et al.Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury[J].Aliment Pharmacol Ther,2008,27(9):780-789.

共引文献56

同被引文献328

引证文献37

二级引证文献214

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部